Rubicon Founders LLC
Follow13F filer, CIK 2032489, NASHVILLE, TN
Rubicon Founders LLC reported $212,753,062 across 3 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002032489-25-000007
- Period
- 2025-06-30
- Reported value
- $213M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| EVHadded | +5,162,600 | $58.1M |
| AGLadded | +102,131 | $235K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q2 2025
Share positions as resolved from 13F-HR 0002032489-25-000007, largest first. % of portfolio is the value over $212,753,062, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| PRVAPRIVIA HEALTH GROUP INC | 5,773,522 | $133M | 62.42% | 0 | The filing omitted confidential holdings, a later amendment may add them. | Timeline | |
| EVHEVOLENT HEALTH INC | 5,816,123 | $65.5M | 30.78% | +5,162,600 | Timeline | ||
| AGLAGILON HEALTH INC COM (DE) | 6,292,396 | $14.5M | 6.8% | +102,131 | Timeline |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002032489-25-000007 | base | 2025-08-14 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0002032489-25-000014 | added | new holdings | 2025-11-17 | acceptance time not in the bulk data set | |
| 13F-HR/A 0002032489-26-000014 | added | new holdings | 2026-05-15 | acceptance time not in the bulk data set |